The Royal College of Ophthalmologists (RCOphth) recommend annual monitoring for retinal toxicity for patients on long-term therapy of Hydroxychloroquine and Chloroquine. This service allows for primary care monitoring of patients within optical practice.
The service aims to identify patients at risk of vision loss through monitoring.
LOCSU’s pathway and clinical management guidelines offer an integrated service delivery model with data collection in primary care and virtual review by a consultant ophthalmologist.
Aligning to the RCOphth guidelines, this allows for patients to be seen within the community in a consultant-led service.
Medical Retina Monitoring – Hydroxychloroquine (November 2023)
This case study looks at Medical Retina Monitoring.
Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening – Royal College of Ophthalmologists guidance
Patient Leaflet – Eye Screening for Patients taking Hydroxychloroquine – Macular Society, Royal College of Ophthalmologists
Next
